The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Fluoroquinolones in animal health
Abstract
The fluoroquinolones are a series of synthetic antibacterial agents that are undergoing extensive investigation for both human and veterinary use in the treatment of a variety of bacterial infections. These agents work through the inhibition of DNA gyrase, interfering with the supercoiling of bacterial chromosomal material. As a result, these agents are rapidly bactericidal primarily against gram‐negative bacteria, mycoplasma, and some grampositive bacteria, with most having little to no activity against group D streptococci and obligate anaerobic bacteria. Resistance develops slowly and is almost always chromosomal and not plasmid‐mediated. However, development of resistance to the fluoroquinolones and transfer of that resistance among animal and human pathogens have become a hotly debated issue among microbiologists. The fluoroquinolones are a current antimicrobial class whose use in veterinary medicine is being scrutinized. From a pharmacokinetic perspective, these agents are variably but well absorbed from the gastrointestinal tract and almost completely absorbed from parenteral injection sites, and they are well distributed to various tissues in the body. The fluoroquinolones are metabolized and renally excreted, with many of them having approximately equal excretion by the hepatic and the renal excretory systems. The primary toxicity observed at therapeutic doses involves the gastrointestinal system and phototoxicity, although at higher doses central nervous system toxicity and ocular cataracts are observed. Administration to immature animals may result in erosive arthropathies at weight‐bearing joints, and administration of high doses to pregnant animals results in maternotoxicity and occasionally embryonic death. The fluoroquinolones are approved for indications such as urinary tract infections and soft tissue infections in dogs and cats and colibacillosis in poultry. Approval for bovine respiratory disease in the United States is being sought. Other indications for which the fluoroquinolones have been used in animal health include deep‐seated infections, prostatitis, and other bacterial infections resistant to standard antimicrobial therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Endtz, H. P., Ruijs, G. J., van Klingeren, B., Jansen, W. H., van der Reyden, T., & Mouton, R. P. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.2.199 · Cited by 590
Blaser, J., Stone, B. B., Groner, M. C., & Zinner, S. H. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1054 · Cited by 481
Drusano, G. L., Johnson, D. E., Rosen, M., & Standiford, H. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.483 · Cited by 426
Nikaido, H., & Thanassi, D. G. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1393 · Cited by 280
Routes of quinolone permeation in Escherichia coli
Chapman, J. S., & Georgopapadakou, N. H. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.4.438 · Cited by 253
Protonation Equilibria of Quinolone Antibacterials
Takács-Novák, K., Noszál, B., Hermecz, I., Keresztúri, G., Podányi, B., & Szasz, G. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600791116 · Cited by 227
Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin
Nix, D. E., Watson, W. A., Lener, M. E., Frost, R. W., Krol, G., Goldstein, H., Lettieri, J., & Schentag, J. J. (1989) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1989.207 · Cited by 186
Brumfitt, W., Franklin, I., Grady, D., Hamilton-Miller, J. M., & Iliffe, A. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.5.757 · Cited by 166
Akahane, K., Sekiguchi, M., Une, T., & Osada, Y. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.10.1704 · Cited by 159
Cited by
Adsorptive removal of antibiotics from aqueous solution using carbon materials
Yu, F., Li, Y., Han, S., & Ma, J. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.03.083 · Cited by 670
Microbial degradation of antibiotic: future possibility of mitigating antibiotic pollution
Kayal, A., & Mandal, S. (2022) · Environmental Monitoring and Assessment · doi:10.1007/s10661-022-10314-2 · Cited by 58
A structural analysis of the FDA green book-approved veterinary drugs and roles in human medicine
Scott, K. A., Qureshi, M. H., Cox, P. B., Marshall, C. M., Bellaire, B. C., Wilcox, M., Stuart, B. A. R., & Njardarson, J. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01502 · Cited by 56
Seal, S., Baruah, M., Majgaonkar, A., Altaf, M., De, P., Umair, M., Sohail, M., & Sinha, D. (2024) · Trends in Biotechnology of Polyextremophiles · doi:10.1007/978-3-031-55032-4_19 · Cited by 3
Metadata
- Authors
- BROWN, S. A.
- Venue
- Journal of Veterinary Pharmacology and Therapeutics
- Publisher
- Wiley
- Published
- 1996-02
- Volume
- 19
- Issue
- 1
- Pages
- 1-14
- ISSN
- 0140-7783 (ISSN-L)
- 1365-2885
- OpenAlex
- W2068301725
- Cited by
- 459
- References
- 33
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fluoroquinolones in animal health. https://app.cochat.ai/papers/10.1111/j.1365-2885.1996.tb00001.x
- The paper
- BROWN, S. A. (1996). Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/j.1365-2885.1996.tb00001.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.